199 related articles for article (PubMed ID: 20856796)
21. Extracellular matrix degradation by cultured mesangial cells: mediators and modulators.
Baricos WH; Reed JC; Cortez SL
Exp Biol Med (Maywood); 2003 Oct; 228(9):1018-22. PubMed ID: 14530509
[TBL] [Abstract][Full Text] [Related]
22. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
[TBL] [Abstract][Full Text] [Related]
23. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
25. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
[TBL] [Abstract][Full Text] [Related]
26. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.
Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615
[TBL] [Abstract][Full Text] [Related]
27. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation.
Hägglund AC; Ny A; Liu K; Ny T
Endocrinology; 1996 Dec; 137(12):5671-7. PubMed ID: 8940398
[TBL] [Abstract][Full Text] [Related]
28. uPA-mediated plasminogen activation is enhanced by polyphosphate.
Whyte CS; Mutch NJ
Haematologica; 2021 Feb; 106(2):522-531. PubMed ID: 32029503
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
30. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
31. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
32. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
33. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
[TBL] [Abstract][Full Text] [Related]
34. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.
Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue.
Dow MP; Bakke LJ; Cassar CA; Peters MW; Pursley JR; Smith GW
Biol Reprod; 2002 May; 66(5):1413-21. PubMed ID: 11967205
[TBL] [Abstract][Full Text] [Related]
36. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.
Singh I; Burnand KG; Collins M; Luttun A; Collen D; Boelhouwer B; Smith A
Circulation; 2003 Feb; 107(6):869-75. PubMed ID: 12591758
[TBL] [Abstract][Full Text] [Related]
37. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.
Ellis V; Danø K
J Biol Chem; 1993 Mar; 268(7):4806-13. PubMed ID: 8444857
[TBL] [Abstract][Full Text] [Related]
39. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes.
Wakita H; Matsushita K; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1998 Mar; 110(3):253-8. PubMed ID: 9506444
[TBL] [Abstract][Full Text] [Related]
40. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
Novokhatny V; Medved L; Lijnen HR; Ingham K
J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
